id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-N-0313-0001,FDA,FDA-2007-N-0313,Maximizing the Public Health Benefit of Adverse Event Collection Throughout a Product's Marketed Life Cycle; Public Workshop; Request for Comments,Notice,NM-Notice of Meeting,2007-12-26T05:00:00Z,2007,12,2007-12-21T05:00:00Z,2008-03-01T04:59:59Z,2008-08-15T01:38:12Z,,0,0,090000648042b70a